These studies were followed by a phase I clinical trial, where allogeneic myoblasts were transplanted into DMD patients, and as expected, dystrophin protein expression was derived from transplanted cells [20,21,22,23]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.